Citations

Clear

13603 citation(s) found for "_, _".

Recovery of the Acute Hypoxic Ventilatory Response: “I Have Given Sugammadex, and the Patient Is Breathing Fine!”
Brull, Sorin J. , Brull, Sorin J , Díaz‐Cambronero, Óscar

Mayo Clinic

Anesthesiology | September 9, 2025 | Volume: 143 | Issue: 4 | Pages: 810-812

10.1097/aln.0000000000005678 | PMID 40923818 Get It

Symptoms of Allodynia and Pain Thresholds Amongst Those with Acute Post-Traumatic Headache Attributed to Mild Traumatic Brain Injury: A Prospective, Longitudinal Study
Ziff, Noah, Garza, Santiago, Starling, Amaal J. , Esterov, Dmitry , Barrett, Kevin M. , Ross, Katherine , Anderson, Trent , Nikolova, Simona , Li, Jing, Huentelman, Matthew J. , Starling, Amaal, Dumkrieger, Gina , Garza, Santiago, Porreca, Frank , Navratilova, Edita , Wu, Teresa , Chong, Catherine D. , Schwedt, Todd J.

Mayo Clinic

No container title available | September 9, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-7511029/v1 | PMID 40964034 Get It

Abstract Background Post-traumatic headache (PTH) is a common acute and persistent symptom following mild traumatic brain injury (mTBI). Symptoms of cutaneous allodynia and presence of nociceptive sensitization might be associated with acute PTH and its persistence. The objectives of this study were to compare allodynia symptoms and cutaneous heat pain thresholds amongst males and females with acute PTH to healthy controls (HC) and determine if pain thresholds and allodynia symptoms are associated with PTH outcomes. Methods This prospective longitudinal study enrolled 139 adults with acute PTH attributed to mTBI as defined by the International Classification of Headache Disorders and 95 HC. All PTH participants completed a baseline research visit near PTH onset and a follow-up visit three to four months later. All PTH participants and a subset of HC completed the Allodynia Symptom Checklist (ASC-12) at each research visit. A different subset of the participants underwent quantitative sensory testing (QST) during baseline, 4-week, and 16-week research visits to quantify cutaneous heat pain thresholds at the forehead and forearms. Data from daily headache diaries were used to determine longitudinal PTH improvement versus non-improvement at three months. ASC-12 score and pain threshold comparisons were made between PTH and HC groups, PTH improved versus non-improved cohorts, and between PTH males and females. Results Participants with PTH had an average age of 42.6 years and 64.0% were female. HC had an average age of 40.0 years and 65.3% were female. At the first visit, PTH participant ASC-12 scores averaged 3.6 versus 0.1 amongst HC, p < 0.001. 44.8% of PTH participants had headache improvement at 3 months. ASC-12 scores were higher in the PTH non-improved versus improved group at baseline (4.0 versus 2.4, p = 0.038) and 3-month follow-up (3.4 versus 1.9, p = 0.012). ASC-12 scores were higher in females than males at baseline (4.7 versus 1.6, p < 0.001) and 3-months (3.9 versus 1.2, p < 0.001). Cutaneous heat pain thresholds at the forehead and forearm did not differ between any group. Conclusions PTH attributed to mTBI is associated with symptoms of cutaneous allodynia. Greater allodynia symptoms are present in females with PTH compared to males and may be associated with PTH non-improvement.
Distinct clinical, laboratory, molecular, and pathologic features of systemic mastocytosis involving the gastrointestinal tract
Chiu, April , Viswanatha, David S., He, Rong , Reichard, Kaaren K. , Tefferi, Ayalew, Pardanani, Animesh , Chen, Dong , Majerus, Julie A. , Chen, Dong , Tefferi, Ayalew

Mayo Clinic

Am J Clin Pathol | September 9, 2025 | Volume: 164 | Issue: 6 | Pages: 879-889

10.1093/ajcp/aqaf112 | PMID 41293991 Get It

Abstract Objective Gastrointestinal (GI) symptoms are common in systemic mastocytosis (SM). We hereby report the clinicopathologic and molecular features of GI mastocytosis. Methods The study includes 104 patients with suspected SM. Of 258 GI biopsy ­specimens, 33 (20 patients, 19%) were mastocytosis-positive, with 19 (16 patients) initially missed. Results Tryptase (n = 29) was weakly positive/negative in two-thirds of the mastocytosis-positive GI biopsy specimens. Additional immunohistochemistry (n = 23) showed positive mast cell expression for CD30 (n = 2), CD123 (n = 7), and PD-L1 (n = 12), as well as increased PD-1–positive cells (n = 4). Sixty patients had positive bone marrow (BM) for SM (SM-BM+), including 19 with positive GI biopsy specimens (SM-GI+). Almost all (43/44) SM-BM– patients were SM-GI–. The SM-GI vs SM-BM status showed high positive predictive value (95%) and specificity (98%). Patients with SM with mastocytosis-positive vs mastocytosis-negative GI biopsy specimens had higher serum tryptase levels (P = .04). KIT D816V mutation was detected in 7 of 13 and 12 of 13 mastocytosis-positive GI biopsy specimens using allele-specific polymerase chain reaction and droplet digital polymerase chain reaction (ddPCR), respectively. Conclusions GI mastocytosis is highly predictive of SM in BM; however, most SM-BM+ patients are SM-GI–. The SM-BM– patients are very unlikely to be SM-GI+. Because GI neoplastic mast cells are often tryptase negative, diagnostic evaluation should include CD117 and CD25 immunohistochemistry, as well as KIT D816V mutation analysis by ddPCR as needed.
Clinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy–Associated Myopathies
Soontrapa, Pannathat , Jones, Felipe J.S. , Milone, Margherita , Pinto, Marcus Vinícius , Malfatti, Edoardo , Pinto, Marcus V , Liewluck, T , Jones, Felipe J S , Soontrapa, Pannathat , Muchtar, Eli , Liewluck, Teerin

Mayo Clinic

Neurology | September 8, 2025 | Volume: 105 | Issue: 7 | Pages: No page available

10.1212/wnl.0000000000214101 | PMID 40921022 Get It

Introduction to the Physiology, Anatomy, and Biochemistry of Autonomic Medicine
Sturgill, Forrest , Shouman, Kamal , Sandroni, Paola , Shouman, Kamal , Sturgill, Forrest L.

Mayo Clinic

Journal of Integrative Neuroscience | September 8, 2025 | Volume: 24 | Issue: 8 | Pages: No page available

10.31083/jin31369 | PMID 40919619 Get It

Autonomic medicine is a rapidly evolving field focused on understanding diseases and processes that affect the autonomic nervous system (ANS). The ANS regulates essential involuntary physiologic processes such as heart rate, blood pressure, and digestion. This review introduces the key anatomical structures, physiological mechanisms, and biochemical processes underlying autonomic function. The anatomy section focuses on the peripheral components of the ANS, including the sympathetic and parasympathetic divisions. The physiological section explores the process of homeostasis and the intricate feedback systems that maintain this balance within the body. Finally, the biochemistry of autonomic signaling, focusing on the neurotransmitters acetylcholine, norepinephrine, and epinephrine, and their receptors, is reviewed. Pertinent clinical points are highlighted throughout, emphasizing the importance of the basic science to the clinical world. This review aims to provide a comprehensive basic science foundation for clinicians and researchers exploring the field of autonomic medicine.
Flap Complications Following Maxillectomy, Reconstructive Surgery, and Postoperative Proton Radiotherapy: A Cohort Study and Considerations for Risk Mitigation
Safavi, Amir H. , Yang, Fan , Wu, Yingzhi, Matros, Evan , Hespe, Geoffrey E. , Gelblum, Daphna Y. , Cohen, Marc A. , Shen, Brian, Sine, Kevin, Mah, Dennis , Lee, Nancy Y. , Gelblum, Daphna Y , Cohen, Marc A , Ganly, Ian , Hung, Tony K. W. , Wong, Richard J. , Han, Dong Soo

Mayo Clinic

Head & Neck | September 8, 2025 | Volume: 48 | Issue: 2 | Pages: 407-415

10.1002/hed.70040 | PMID 40916977 Get It

ABSTRACT Background Flap complications following maxillectomy, reconstruction, and adjuvant proton beam therapy (PBT) for primary maxillary and sinonasal malignancies are not well described. Methods This retrospective cohort study included consecutive patients treated between 2016 and 2023 from a single‐institutional database. Results Thirteen patients were identified with a median follow‐up of 26 months. No immediate post‐operative complications occurred, with a median time between surgery and PBT of 61 days. Nine patients (69.2%) had high‐risk postoperative pathology and required 66+ Gy(RBE), including five (38.5%) with gross disease receiving 70 Gy(RBE). Flap necrosis and fistulization occurred in three patients (23.1%) following PBT (median time from PBT to complication, 112 days). Higher flap mean and minimum dose, flap volume receiving at least 66 Gy[RBE], and minimum dose to 50% flap volume were associated with complications. Conclusions Careful patient selection and planning strategies should be considered to mitigate flap complication risk following adjuvant PBT for high‐risk post‐operative pathology.
Rising Obesity-Related Cardiovascular Mortality in the United States, 1999–2020: Accelerating Trends and Widening Disparities
Pavuluri, Sai Swetha, Kataveni, Suhas , Trivedi, Shashank , Pasupuleti, Suman, Sahai, Akshat, Haidar, Salar, Vashisht, Kumar, Adithya, Vikram, Lanka, Nidhi, Sharma, Gaurav , Pasupuleti, Suman, Sahai, Akshat, Haidar, Salar

Mayo Clinic

No container title available | September 7, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-7530128/v1 Get It

Abstract Obesity is a major and growing driver of cardiovascular disease (CVD) in the United States, contributing to hypertension, diabetes, dyslipidemia, and structural cardiac changes that elevate the risk of ischemic heart disease, heart failure, and stroke. After decades of declining CVD mortality, recent national trends show a concerning reversal, coinciding with record-high obesity prevalence. We quantified national trends and disparities in obesity-related CVD mortality from 1999–2020 using de-identified death certificate data from the CDC WONDER database for U.S. residents aged 15–84 years, including deaths with circulatory disease (ICD-10 I00–I99) as the underlying cause and obesity (E66.0–E66.9) as a contributing cause. Age-adjusted mortality rates (AAMR) standardized to the 2000 U.S. population were analyzed using joinpoint regression to estimate annual percent change (APC) and detect inflection points. From 1999–2018, AAMR rose from 2.75 to 6.61 per 100,000 (APC 4.79%; 95% CI 4.60–4.98), followed by a significant post-2018 acceleration (APC 11.05%; 95% CI 6.76–15.51) to 8.36 in 2020. Mortality was highest among adults 65–74 years, males, Black Americans, and nonmetropolitan residents, with a 5.1-fold state variation. Young adults (15–24 years) had the largest relative increase (+210%). The 2020 surge was independent of COVID-19 mortality, indicating gaps in chronic disease management. These results highlight a growing obesity-related CVD mortality burden, with widening disparities by age, sex, race, and geography, emphasizing urgent, equity-focused prevention and targeted interventions.
Klebsiella pneumoniae Invasive Syndrome without Liver Abscess: A Case Report
Dhamelia, Parth M. , Mokariya, Dipak R., Anand, Jaspreet Singh , Chitale, Rohit , Oring, Justin , Anand, Jaspreet Singh

Mayo Clinic

American Journal of Case Reports | September 5, 2025 | Volume: 26 | Issue: No issue available | Pages: No page available

10.12659/ajcr.949163 | PMID 41084227 Get It

Sudden Death in Children and Young Adults: Etiologies, Risk Stratification, and Prevention Strategies
Ahmad, Rimsha , Arslan, Fatima Safi , Niaz, Mahnoor, Hussain, Syed Sadam, Frishman, William H., Aronow, Wilbert S., Khan, Saifullah , Kumar, Mahesh , Aronow, Wilbert S.

Mayo Clinic

Cardiology in Review | September 5, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/crd.0000000000001043 | PMID 40910770 Get It

Sudden death in children and young adults, while uncommon, carries profound clinical and societal implications. Cardiac causes, particularly inherited arrhythmias and cardiomyopathies, account for most cases, though neurologic, toxicologic, traumatic, and infectious etiologies also contribute significantly. This review explores the epidemiology, classification, and pathophysiologic mechanisms of sudden death in this population, emphasizing early clinical warning signs and identifiable risk factors. We also outline diagnostic and preventive strategies, including electrocardiography, genetic testing, and postmortem evaluation. Despite guidelines advocating preparticipation screening, real-world implementation remains inconsistent. Advances in genomics and artificial intelligence offer new opportunities for early risk detection. Finally, we discuss public health interventions such as defibrillator access, cardiopulmonary resuscitation education, and school-based protocols as essential components of a broader prevention strategy.
AIM (Anticipate/Adjust, Image, Manage) to Prevent Bleeding During Robotically‐Assisted Bronchoscopic Ablation
Fernández-Bussy, Sebastián , Kornafeld, Anna , Husta, Bryan , Vu, Linh H. , Lee‐Mateus, Alejandra Yu , Alqawasma, Mohammed A., Yu Lee-Mateus, Alejandra , Abia‐Trujillo, David

Mayo Clinic

Respirology Case Reports | September 5, 2025 | Volume: 13 | Issue: 9 | Pages: No page available

10.1002/rcr2.70335 | PMID 40917250 Get It

ABSTRACTTherapeutic treatment of lung nodules by ablation is a new field. Even though not considered standard of care, lung nodule ablation can be appropriate for select cases. Even though ablation is a safe and well‐tolerated procedure, bleeding is a potential complication. We introduce our stepwise approach through two cases on how we AIM (Anticipate/Adjust, Image, Manage) to prevent uncontrolled bleeding during Robotically Assisted Bronchoscopic Ablation: 1. Anticipate structures with high risk for bleeding and adjust accordingly, accounting for the needle ablation field; 2. Image: utilise cone beam CT before the first and after each ablation session to screen for bleeding; 3. Manage bleeding by pre‐emptively utilising Fogarty balloon occlusion.